Effect of Whole-body Vibration on Postural Stability, Muscle Flexibility and Lower Limb Power in Young Basketball Players with Generalized Joint Hypermobility

The goal of this clinical trial is to assess the effect of whole body vibration (WBV) on postural stability, flexibility of the lumbar-pelvic-hip complex and lower leg muscles, and jumping ability in basketball players aged 9-15 years. The main questions it aims to answer are:

Does WBV affect the level of postural stability in basketball players aged 9-15 years? Does WBV affect the level of postural stability in basketball players aged 9-15 years? Does WBV affect the flexibility of the iliopsoas, rectus femoris, posterior group of hamstrings, soleus and gastrocnemius in basketball players aged 9-15 years? Does WBV affect the jump height, relative peak power, contraction time in basketball players aged 9-15 years?

Participants will take part in 6 vibration sessions at 20Hz over 6 weeks. Vibration will be performed on the Galileo Med35 platform (3x3 min).

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Men aged 9-15
  • Playing basketball in a sports club at least 2 training sessions a week

Exclusion Criteria:

  • Thrombosis (acute narrowing of blood vessels),
  • Inflammation of the musculoskeletal system,
  • Arthropathy,
  • Hernias,
  • Discopathies,
  • Tendonitis,
  • Fresh fractures,
  • Scars,
  • Surgeries,
  • Kidney stones,
  • Rheumatoid arthritis,
  • Implants in the body,
  • Epilepsy,
  • Current injuries to the musculoskeletal system,
  • Occurrence of chronic pain complaints of the musculoskeletal system.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Generalized Joint Hypermobility
Whole body vibration consists of 3-minute vibrations with a 30-second break. Participants were asked to step onto the platform barefoot and position their feet "3" from the center of the platform, with feet pointing forward, knees slightly bent, and upper limbs along the body. The training was divided into two parts: week 1 with a frequency of 20 Hz, and a constant amplitude of 3 mm.
Experimental: Not Generalized Joint Hypermobility
Whole body vibration consists of 3-minute vibrations with a 30-second break. Participants were asked to step onto the platform barefoot and position their feet "3" from the center of the platform, with feet pointing forward, knees slightly bent, and upper limbs along the body. The training was divided into two parts: week 1 with a frequency of 20 Hz, and a constant amplitude of 3 mm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Postural Stability
Time Frame: 6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
Postural stability was measured as the overall stability index (OSI) on the Biodex Balance System on the stable and unstable platform with open and closed eyes.
6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
Range of motion (ROM) of the ankle, knee, and hip joints.
Time Frame: 6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
Range of motion (ROM) of the ankle, knee, and hip joints, will be measured in a resting position using an inclinometer for the iliopsoas, rectus femoris, posterior hamstring, soleus, and gastrocnemius muscles separately.
6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
Countermovement Jump Performance
Time Frame: 6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.
Countermovement jump performance will be measured by using force plates, It will be assessed Jump height (JH), relative peak power (RPP), and contraction time (CT).
6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 20, 2025

Primary Completion (Estimated)

June 4, 2025

Study Completion (Estimated)

June 4, 2025

Study Registration Dates

First Submitted

November 8, 2024

First Submitted That Met QC Criteria

November 14, 2024

First Posted (Actual)

November 15, 2024

Study Record Updates

Last Update Posted (Actual)

November 15, 2024

Last Update Submitted That Met QC Criteria

November 14, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • AWFiS/2024_4_OF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Generalized Joint Hypermobility

Clinical Trials on Whole Body Vibration

Subscribe